Chemoinformaics analysis of p-Coumarylquinic acid
Molecular Weight | 442.728 | nRot | 5 |
Heavy Atom Molecular Weight | 392.328 | nRig | 24 |
Exact Molecular Weight | 442.381 | nRing | 5 |
Solubility: LogS | -2.237 | nHRing | 0 |
Solubility: LogP | 1.652 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 5 |
No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 85.0436 |
nHD | 2 | BPOL | 50.1604 |
QED | 0.221 |
Synth | 5.801 |
Natural Product Likeliness | 1.845 |
NR-PPAR-gamma | 0.047 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.006 |
Pgp-sub | 0.052 |
HIA | 0.778 |
CACO-2 | -5.486 |
MDCK | 0.000126607 |
BBB | 0.166 |
PPB | 0.288807 |
VDSS | 0.826 |
FU | 0.612515 |
CYP1A2-inh | 0.007 |
CYP1A2-sub | 0.068 |
CYP2c19-inh | 0.013 |
CYP2c19-sub | 0.571 |
CYP2c9-inh | 0.003 |
CYP2c9-sub | 0.065 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.162 |
CYP3a4-inh | 0.035 |
CYP3a4-sub | 0.415 |
CL | 2.077 |
T12 | 0.103 |
hERG | 0.012 |
Ames | 0.04 |
ROA | 0.829 |
SkinSen | 0.031 |
Carcinogencity | 0.949 |
EI | 0.007 |
Respiratory | 0.85 |
NR-Aromatase | 0.451 |
Antiviral | No |
Prediction | 0.727541 |